.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A08A_AntiobesityPreparationsExclDietProducts.A08AA09_Mefenorex.Mefenorex .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A08A_AntiobesityPreparationsExclDietProducts.A08AA09_Mefenorex.Mefenorex| name: | Mefenorex | |
| ATC code: | A08AA09 | route: | oral |
| compartments: | 1 | |
| dosage: | 50 | mg |
| volume of distribution: | 3.0 | L |
| clearance: | 3.5 | L/h/kg |
| other parameters in model implementation | ||
Mefenorex is an amphetamine derivative that was used as an anorectic agent for weight loss management in the treatment of obesity. Due to concerns about amphetamine-like side effects and potential for abuse, mefenorex has been withdrawn from the market and is not approved for use in most countries today.
No dedicated peer-reviewed pharmacokinetic studies in humans could be identified. Pharmacokinetic parameters are estimated based on structurally similar amphetamine derivatives with oral administration in healthy adults.